18.97.14.85
18.97.14.85
close menu
Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer
( Yu Mi Lee ) , ( Soo Young Lee ) , ( Sun Jung Kwon ) , ( Eugene Choi ) , ( Moon Jun Na ) , ( Young Jin Kim ) , ( Hyun Min Cho ) , ( Jae Ku Kang ) , ( Ji Woong Son )
UCI I410-ECN-0102-2013-510-002463554
This article is 4 pages or less.

Histone deacetylases (HDACs) play a crucial role in tumorigenesis. Over-expression of HDACs has been reported in lung cancer. The mechanism of highly expressed HDAC1 in lung cancer has yet not been determined. In the present study, we showed that miR-449a/b regulates HDAC1 by directly binding with the 3`untranslated region of the HDAC1. The expression of miR-449a/b was down-regulated and the expression of HDAC1 was up-regulated in primary lung cancer. The down expression of miR-449a/b might be one mechanism for over-expression of HDAC1 in lung cancer. miR-449a/b inhibited cell growth and anchorage-independent growth. Furthermore, co-treatment with miR-449a and HDAC inhibitors had a significant growth reduction compared with HDAC inhibitors mono-treatment. These results suggest that miR-449a/b may has a tumor suppressor function and might be a potential therapeutic candidate in patients with primary lung cancer.

[자료제공 : 네이버학술정보]
×